Yourgene Health plc
(“Yourgene” or the “Company”)
Notice of AGM
Manchester, UK – 20 August 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Annual General Meeting (AGM) will be held at 4:00pm on 17 September 2019 at Citylabs 1.0, Nelson Street, Manchester M13 9NQ.
Ahead of the meeting, the Chair will introduce shareholders to newly appointed Non-executive Directors, Dr John Brown CBE and Jonathan Seaton. In addition, the Company’s CEO, Lyn Rees, will provide shareholders with a short presentation after the formal business of the AGM is concluded.
The Notice of AGM and Form of Proxy are being posted to shareholders and will shortly be available on the Company’s website at:
www.yourgene-health.com/investors/key-documents/shareholder-communications
The Annual Report and Accounts for the year ended 31 March 2019, published on 10 July 2019, are available at:
www.yourgene-health.com/investors/key-documents/financial-reports
For more information, please contact: | |
Yourgene Health plc | Tel: +44 (0)161 667 1053 |
Cairn Financial Advisers LLP (NOMAD) | Tel: +44 (0)20 7213 0880 |
Stifel Nicolaus Europe Limited (Sole Corporate Broker) | Tel: +44 (0)20 7710 7600 |
Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com |
